Para a página inicial
820К+ pacientes receberam assistência desde 2014
50 países
1,500 clínicas
6K+ avaliações
3K+ médicos qualificados

Qual é o custo para procedimentos de diagnóstico e tratamento de Carcinomatose em Índia? Descubra agora

O preço médio para diagnóstico e tratamento de Carcinomatose em Índia é $18,500, o preço mínimo é $17,000 e o máximo é $20,000.
Dados verificados pela Bookimed em July 2026, com base em solicitações de pacientes e cotações oficiais de 65 clínicas em todo o mundo. Os custos medianos são baseados em faturas reais (2025–2026) e atualizados mensalmente. Os preços reais podem variar.

Seus Benefícios e Garantias com a Bookimed

Preços Diretos

A Bookimed não adiciona taxas extras aos preços de tratamento de Carcinomatose. As tarifas vêm das listas oficiais de preços das clínicas. O pagamento é feito diretamente na clínica na chegada ao país.

Somente Clínicas e Médicos Verificados

A Bookimed está comprometida com sua segurança. Trabalha apenas com instituições que mantêm altos padrões internacionais no tratamento de Carcinomatose e têm as licenças necessárias para atender pacientes internacionais em todo o mundo.

Assistência gratuita 24/7

A Bookimed oferece assistência gratuita de especialistas. Um coordenador médico pessoal apoia antes, durante e após o tratamento, solucionando problemas. Nunca está sozinho em sua jornada de tratamento de Carcinomatose.

Por que nós?

Seu assistente Bookimed pessoal

  • Apoia em cada etapa
  • Ajuda a escolher clínica e médico adequados
  • Garante acesso rápido e conveniente à informação

Descubra as Melhores Clínicas de Carcinomatose em Índia: 8 opções verificadas e preços

As clínicas são classificadas pelo sistema inteligente da Bookimed, com análise de ciência de dados em 5 critérios principais.
Manipal Hospitals
Medanta Hospital
4.0
Preço sob consulta
Página da clínica
Global Hospital Chennai
Global Hospital Mumbai

Obtenha uma avaliação médica para Carcinomatose em Índia: consulte agora médicos experientes

Ver todos os médicos
verificado

Raj Nagarkar

30 anos de experiência

O Dr. Raj realizou mais de 50.000 cirurgias oncológicas ao longo de 19 anos, especializando-se em Oncologia Cirúrgica Mamária e Torácica no HCG Manavata Cancer Centre.

  • Formado no Tata Memorial Hospital e no Royal College of Surgeons, Edimburgo
  • Envolvido em mais de 200 ensaios clínicos, incluindo estudos de fase 1-3
  • Professor de Subespecialidade DNB em Oncologia Cirúrgica e Cirurgia de Mama
  • Focar na melhoria da qualidade de vida dos pacientes em paralelo ao tratamento
verificado

Shruti Kate

15 anos de experiência

A Dra. Shruti Kate é especializada em tratamentos avançados contra o câncer, incluindo imunoterapia e terapia metronômica. Ela formou-se no Tata Memorial Hospital – o principal centro de oncologia da Índia.

  • Ser especialista em cancros do pulmão, da mama e ginecológicos
  • Ser membro da ASCO, ESMO e outras sociedades oncológicas de topo
  • Apresentar investigação sobre o cancro do pulmão na Conferência Mundial sobre o Cancro do Pulmão
  • Utilizar abordagens inovadoras para casos de cancro avançado
verificado

Chaitainya Borde

11 anos de experiência

Mais de 30.000 exames de PET realizados e 1.000 pacientes com cancro da tiroide tratados – o Dr. Borde é especialista em medicina nuclear no HCG Manavata Cancer Centre.

  • 12 anos de experiência em medicina nuclear
  • Proficiente em terapias com radioiodo e Lu-177 RN
  • Especialista em todos os tipos de exames nucleares e PET-CT
  • Artigos publicados em diversas revistas médicas

Compartilhar este conteúdo

Histórias em vídeo de pacientes da Bookimed

Dayana
I combined my vacation in Antalya with a check-up.
Procedimento: Check-up feminino
Igor
It was great! Transfers, accommodation, treatment—all included.
Procedimento: Implante Dentário
Clínica: WestDent Clinic
Marina
Bookimed did everything for me. I didn't have to worry about anything.
Procedimento: Check-up feminino
Atualizado: 05/27/2022
Autoria de
Anna Leonova
Anna Leonova
Chefe da Equipe de Marketing de Conteúdo
Redator médico certificado com mais de 10 anos de experiência, desenvolveu o conteúdo confiável do Bookimed, apoiado por Mestrado em Filologia e entrevistas com especialistas médicos em todo o mundo.
Fahad Mawlood
Editor médico e cientista de dados
Clínico geral. Vencedor de 4 prêmios científicos. Atuou na Ásia Ocidental. Ex-líder de equipe médica que atendia pacientes de língua árabe. Agora responsável pelo processamento de dados e precisão do conteúdo médico.
Fahad Mawlood Linkedin
Esta página pode conter informações relacionadas a várias condições médicas, tratamentos e serviços de saúde disponíveis em diferentes países. O conteúdo é fornecido apenas para fins informativos e não deve ser interpretado como orientação ou aconselhamento médico. Consulte um médico ou profissional de saúde qualificado antes de iniciar ou alterar qualquer tratamento médico.

FAQ sobre Tratamento de Carcinomatose em Índia

Estas Perguntas Frequentes provêm de pacientes reais que procuram assistência médica através da Bookimed. As respostas são dadas por coordenadores médicos experientes e representantes de confiança das clínicas.

Who is an ideal candidate for CRS and HIPEC treatment?

Ideal candidates for cytoreductive surgery (CRS) and hyperthermic intraperitoneal chemotherapy (HIPEC) have advanced cancer confined strictly to the abdominal cavity. Patients must demonstrate high physical fitness to endure multisour procedures. Surgeons must be able to achieve complete removal of all visible tumor masses.

  • Tumor location: Disease must remain localized within the peritoneal cavity without spreading elsewhere.
  • Primary cancer types: Most favorable for appendix cancer, pseudomyxoma peritonei, and colorectal or ovarian cancers.
  • Surgical feasibility: Specialists use CT or PET-CT to ensure complete resection is achievable.
  • Physical health: Patients require strong cardiac and renal function for intensive 8–12 hour operations.

Bookimed Expert Insight: Indian centers like Global Hospital Chennai and HCG Manavata Cancer Centre use PET-CT and diagnostic laparoscopy to avoid surgical surprises. Data shows that high-volume clinics treating 75,000+ patients annually apply stricter selection criteria. This rigor often leads to higher success in achieving complete cytoreduction.

Patient Consensus: Patients emphasize that specialized peritoneal surgeons may find cases operable even when general oncologists are hesitant. Many suggest that maintaining mobility and nutrition before the evaluation significantly improves the chances of being accepted for treatment.

What is the success rate of Carcinomatosis treatment in India?

Success rates for carcinomatosis treatment in India show a 60–80% histological response when using Pressurized Intraperitoneal Aerosol Chemotherapy (PIPAC). Advanced centers also achieve improved survival through cytoreductive surgery combined with Hyperthermic Intraperitoneal Chemotherapy (HIPEC). Outcomes depend on the primary cancer type and disease extent.

  • Response rates: PIPAC technology achieves 60–80% cancer cell reduction in peritoneal cases.
  • Survival outcomes: Advanced ovarian carcinomatosis shows approximate 10-year survival rates of 15–30%.
  • Treatment focus: Specialists combine aggressive surgery with HIPEC to control stage IV spread.
  • Center expertise: Accredited facilities like Artemis and Manipal provide protocol-based, multidisciplinary care.

Bookimed Expert Insight: Success in treating carcinomatosis in India often correlates with the high surgical volumes of leading oncologists. Dr. Raj Nagarkar at HCG Manavata has performed over 50,000 cancer surgeries. This level of experience is vital because surgical candidacy—the biggest factor in long-term survival—is often determined during the operation itself. India’s largest centers, serving up to 2,000,000 patients annually, offer the specialized infrastructure necessary for these complex 8–12 hour procedures.

Patient Consensus: Patients note that success often means long-term disease control rather than a full cure. Many emphasize seeking second opinions from tertiary centers to confirm if they are candidates for HIPEC surgery.

Does health insurance cover advanced carcinomatosis treatments in India?

Health insurance in India covers advanced carcinomatosis treatments through indemnity policies or critical illness plans. Coverage includes modern procedures like HIPEC (Hyperthermic Intraperitoneal Chemotherapy). IRDAI regulations mandate that insurers cover advanced therapies, robotic surgeries, and targeted chemotherapy under modern treatment clauses.

  • Modern treatments: Modalities like HIPEC receive partial or full coverage under IRDAI mandates.
  • Hospitalization limits: Major tumor debulking surgeries are covered up to the specific sum insured.
  • Waiting periods: Critical illness plans typically require a 90-day waiting period before claim eligibility.
  • Policy exclusions: Expenses for specialized disposables or experimental drugs may require out-of-pocket payments.

Bookimed Expert Insight: While major centers like Artemis Hospitals or Manipal Hospitals hold JCI and NABH accreditations, insurance payouts often depend on facility categorization. High-volume centers like Global Hospital Chennai serve 80,000 patients annually, making them more likely to have established cashless desks. Choosing a JCI-accredited hospital usually ensures more standardized billing for complex oncology claims.

Patient Consensus: Patients note that coverage is often partial. Pre-authorization is essential because insurers may label parts of high-cost surgical care as investigational or elective after discharge.

What is the recovery timeline after receiving CRS and HIPEC?

Recovery after CRS and HIPEC in India usually takes 3 to 6 months. Patients typically spend 7 to 14 days in specialized oncology centers like Global Hospital or Artemis. Full physiological return to pre-operative levels often requires up to 1 year for extensive peritonectomy cases.

  • Hospital stay: Expect 1–3 weeks depending on bowel function and primary wound healing.
  • Initial phase: Fatigue and digestive changes are common during the first 2 months.
  • Activity resumption: Most patients return to light work or tasks after about 8 weeks.
  • Full stamina: Normal energy levels and appetite typically return 6 months after surgery.

Bookimed Expert Insight: Indian oncology centers like HCG Manavata feature high-volume surgeons such as Dr. Raj Nagarkar, who has performed over 50,000 surgeries. Data suggests that choosing high-volume specialists is vital for HIPEC, as `stunned` bowel recovery depends heavily on intraoperative precision and post-operative nutritional management. In India, some facilities also use IBM Watson to tailor recovery protocols specifically to the patient’s unique tumor biology.

Patient Consensus: Patients note that recovery happens in 2 stages: first leaving the hospital, then slowly rebuilding nutrition and weight over several months. Many emphasize that having help at home for the first few weeks is essential as stamina returns very gradually.

Which hospitals in India are well-equipped for Carcinomatosis treatment?

Indian oncology centers provide specialized treatment for carcinomatosis through cytoreductive surgery and hyperthermic intraperitoneal chemotherapy (HIPEC). Major facilities in Gurugram, Mumbai, and Chennai maintain National Accreditation Board for Hospitals and Healthcare Providers (NABH) standards. Leading units utilize multidisciplinary tumor boards to manage advanced peritoneal malignancies.

  • Specialized infrastructure: Facilities like Artemis Hospitals and Medanta hold Joint Commission International accreditation.
  • Advanced technology: Dr. Rela Institute uses linear accelerators with 1 mm precision for targeting.
  • Nuclear medicine: HCG Manavata Cancer Centre has managed over 30,000 PET-CT scans for staging.
  • Experience levels: Top surgeons like Dr. Raj Nagarkar have performed over 50,000 cancer surgeries.

Bookimed Expert Insight: While many general hospitals offer oncology, focusing on centers with high-volume peritoneal surface departments is essential. For instance, HCG Manavata Cancer Centre has treated over 100,000 global patients. This high volume often correlates with refined surgical protocols for complex cytoreductive procedures. Clinics like Manipal Goa even integrate IBM Watson to assist in selecting precise treatment paths.

Patient Consensus: Patients emphasize choosing clinics where surgery, radiology, and ICU support coexist in one building. They also recommend bringing original pathology slides for a second opinion before starting intensive HIPEC protocols.

Obtenha uma consulta gratuita

Selecione a melhor forma de contato